SGLT2, Cardiomyocytes, Cardiovascular Disease, Diabetes mellitus
SGLT2, Cardiomyocyte, cardiovascular Disease, Diabetes Mellitus
BNCT, patient activation, Dosimetry, excretes activation, Radiation protection
HFrEF, CRTd non-responders, miRs regulation, clinical outcomes